CODING BIO LIMITED
Company number 13043546 · Active · Oxford OX3 0BP
CODING BIO LIMITED is an active private limited company (company number 13043546) incorporated on 25 November 2020, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 November 2025, showing net assets of −£2.22m and cash of £2.29m, with 17 employees on average. Net assets fell 622% on the prior period (−£307k). Across the last 3 periods on record the net-asset trend is falling.
By net assets it sits in the bottom quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
Key dates
- Incorporated
- 25 November 2020
- Next accounts due
- 30 August 2027 — in 316 days
- Confirmation statement due
- 9 December 2026 — in 52 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- Micro (Companies Act thresholds)
Financials — 3 periods on record, latest ending 30 November 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | −£2.22m | £2.29m | — | £252k | — | — | 17 |
| 30 November 2024 | −£307k | £2.46m | — | £132k | — | — | 17 |
| 30 November 2023 | £1.07m | £4.30m | — | £55k | — | — | 13 |
- Current ratio
- 11.15 — comfortable
- Cash per employee
- £135k
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 52/100 (grade C)
- -15 Negative net assets — Net assets £-2,216,414 at 2025-11-30
- -8 Net assets falling — -621.7% vs prior period
- +8 Comfortable liquidity — Current ratio 11.15
- +4 Cash reserves — Cash £2,288,558
- +5 Multi-year filing history — 3 periods on record
- +8 Established — Incorporated 2020-11-25 (6 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- (persons with significant control statement) — · since 3 November 2022
- Ms Youlia Lampi — owns 25–50% of shares; holds 25–50% of voting rights · since 25 November 2020 · ceased 9 November 2022
- Mr Simon Bornschein — owns 25–50% of shares; holds 25–50% of voting rights · since 25 November 2020 · ceased 9 November 2022
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Oxford
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- TROCEPT THERAPEUTICS LIMITED — Oxford, inc. Nov 2020
- ACCESSION THERAPEUTICS LIMITED — Oxford, inc. Dec 2020
- KLEIDOX THERAPEUTICS LTD — Oxford, inc. Nov 2020
- AMBER THERAPEUTICS HOLDINGS LIMITED — Didcot, inc. Dec 2020
- EPTIVA THERAPEUTICS LTD — Oxford, inc. Oct 2020
- THIRTYFIVEBIO LIMITED — Abingdon, inc. Jan 2021
Reminders for CODING BIO LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.